Heritage Medical Systems has backed a $25m series B round for the Caltech spinout, which is developing therapies for Parkinson’s and Autism spectrum disorder.

US-based biopharmaceutical company Axial Biotherapeutics completed a $25m series B round yesterday that included a commitment from healthcare provider Heritage Medical Systems. Health for Life Capital, a fund managed by Seventure Partners, led the round, investing alongside investment managers Longwood Fund and Domain Associates, as well a group of high-net-worth individuals based in Southern California.…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.